Literature DB >> 19590527

The cytotoxic macrolide FD-891 induces caspase-8-dependent mitochondrial release of cytochrome c and subsequent apoptosis in human leukemia Jurkat cells.

Susumu Inaba1, Tadashi Eguchi, Atsushi Motegi, Kazutoshi Mizoue, Takeo Usui, Kazuo Nagai, Takao Kataoka.   

Abstract

The 16-membered macrolide FD-891 exerts cytotoxicity toward several cancer cell lines. In this study, we showed that FD-891 induces apoptosis in various human cancer cell lines. Human leukemia Jurkat cells were highly sensitive to FD-891, exhibiting caspase activation and mitochondrial release of cytochrome c into the cytosol at early time points after exposure to FD-891. By contrast, Jurkat cells deficient in caspase-8 were resistant to FD-891-induced apoptosis and manifested little induction of cytochrome c release as well as caspase-9 processing. Consistent with these results, the overexpression of the Bcl-2 family member Bcl-x(L) or the caspase-8 modulator c-FLIP(L) markedly prevented FD-891-induced apoptosis. These results clearly demonstrate that FD-891 triggers caspase-8-dependent mitochondrial release of cytochrome c and subsequent apoptosis in Jurkat cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590527     DOI: 10.1038/ja.2009.62

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  2 in total

1.  Synthesis and structure-activity relationship study of FD-891: importance of the side chain and C8-C9 epoxide for cytotoxic activity against cancer cells.

Authors:  Tomohiro Itagaki; Ayano Kawamata; Miho Takeuchi; Keisuke Hamada; Yoshiharu Iwabuchi; Tadashi Eguchi; Fumitaka Kudo; Takeo Usui; Naoki Kanoh
Journal:  J Antibiot (Tokyo)       Date:  2016-01-27       Impact factor: 2.649

2.  Underlying mechanism of protection from hypoxic injury seen with n-butanol extract of Potentilla anserine L. in hippocampal neurons.

Authors:  Xiaojing Qin; Lingzhi Li; Qi Lv; Baoguo Yu; Shuwang Yang; Tao He; Yongliang Zhang
Journal:  Neural Regen Res       Date:  2012-11-25       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.